Karel Chalupský

2.1k total citations
55 papers, 1.5k citations indexed

About

Karel Chalupský is a scholar working on Molecular Biology, Physiology and Biochemistry. According to data from OpenAlex, Karel Chalupský has authored 55 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Physiology and 11 papers in Biochemistry. Recurrent topics in Karel Chalupský's work include Nitric Oxide and Endothelin Effects (15 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Liver physiology and pathology (5 papers). Karel Chalupský is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and Liver physiology and pathology (5 papers). Karel Chalupský collaborates with scholars based in Czechia, France and United States. Karel Chalupský's co-authors include Hua Cai, Ivan Kanchev, Radislav Sedláček, Ling Gao, Enrico Stefani, Bernard Müller, Valérie B. Schini‐Kerth, Jean‐Claude Stoclet, Martin Gregor and Markéta Jiroušková and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Karel Chalupský

53 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karel Chalupský Czechia 21 497 463 227 216 168 55 1.5k
Doina Popov Romania 25 785 1.6× 495 1.1× 364 1.6× 240 1.1× 99 0.6× 65 2.1k
Yasuhiro Irino Japan 27 1.1k 2.2× 386 0.8× 164 0.7× 157 0.7× 128 0.8× 62 2.1k
Akihide Nakao Japan 18 345 0.7× 321 0.7× 166 0.7× 164 0.8× 149 0.9× 36 1.4k
Dongxiao Shen United States 16 847 1.7× 345 0.7× 165 0.7× 126 0.6× 87 0.5× 24 1.6k
Ken Y. Lin United States 16 531 1.1× 420 0.9× 383 1.7× 344 1.6× 108 0.6× 32 1.8k
Barbara Coles United Kingdom 19 590 1.2× 332 0.7× 217 1.0× 327 1.5× 325 1.9× 33 1.5k
Wei Cui China 22 562 1.1× 310 0.7× 185 0.8× 233 1.1× 76 0.5× 55 1.5k
Kenji Kasuno Japan 16 785 1.6× 515 1.1× 127 0.6× 140 0.6× 82 0.5× 44 1.8k
Alice Habermeier Germany 19 499 1.0× 727 1.6× 458 2.0× 244 1.1× 495 2.9× 32 1.8k
Adrian Manea Romania 25 659 1.3× 466 1.0× 159 0.7× 601 2.8× 63 0.4× 42 1.7k

Countries citing papers authored by Karel Chalupský

Since Specialization
Citations

This map shows the geographic impact of Karel Chalupský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Chalupský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Chalupský more than expected).

Fields of papers citing papers by Karel Chalupský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karel Chalupský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Chalupský. The network helps show where Karel Chalupský may publish in the future.

Co-authorship network of co-authors of Karel Chalupský

This figure shows the co-authorship network connecting the top 25 collaborators of Karel Chalupský. A scholar is included among the top collaborators of Karel Chalupský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Chalupský. Karel Chalupský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chalupská, Dominika, Milan Dejmek, Michal Šála, et al.. (2024). Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides. RSC Medicinal Chemistry. 15(10). 3469–3476. 5 indexed citations
2.
Krafčíková, Petra, et al.. (2024). Structural and functional insights in flavivirus NS5 proteins gained by the structure of Ntaya virus polymerase and methyltransferase. Structure. 32(8). 1099–1109.e3. 3 indexed citations
3.
Řezníčková, Eva, Radek Jorda, Milan Dejmek, et al.. (2023). Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping. Journal of Medicinal Chemistry. 66(16). 11133–11157. 8 indexed citations
4.
Dušek, Ján, Karel Chalupský, Ivona Pávková, et al.. (2023). Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2-a]pyridine Structure. Journal of Medicinal Chemistry. 66(4). 2422–2456. 13 indexed citations
5.
Chalupská, Dominika, Karel Chalupský, Petra Krafčíková, et al.. (2023). Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. ACS Omega. 8(30). 27410–27418. 13 indexed citations
6.
Šilhán, Jan, Martin Klíma, Dominika Chalupská, et al.. (2023). Discovery and structural characterization of monkeypox virus methyltransferase VP39 inhibitors reveal similarities to SARS-CoV-2 nsp14 methyltransferase. Nature Communications. 14(1). 2259–2259. 29 indexed citations
7.
Chalupský, Karel, et al.. (2021). ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis. Scientific Reports. 11(1). 11414–11414. 20 indexed citations
8.
Hodek, Jan, Karel Chalupský, Martin Dračínský, et al.. (2021). Discovery of Modified Amidate (ProTide) Prodrugs of Tenofovir with Enhanced Antiviral Properties. Journal of Medicinal Chemistry. 64(22). 16425–16449. 13 indexed citations
9.
Hodek, Jan, Karel Chalupský, Petra Krafčíková, et al.. (2021). Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit. Viruses. 13(8). 1487–1487. 11 indexed citations
10.
Chalupský, Karel, Markus F. Templin, Jana Maixnerová, et al.. (2021). Off-target lipid metabolism disruption by the mouse constitutive androstane receptor ligand TCPOBOP in humanized mice. Biochemical Pharmacology. 197. 114905–114905. 7 indexed citations
11.
Kračun, Damir, Andreas Petry, Ivan Kanchev, et al.. (2020). NADPH oxidases and HIF1 promote cardiac dysfunction and pulmonary hypertension in response to glucocorticoid excess. Redox Biology. 34. 101536–101536. 15 indexed citations
12.
Kašpárek, Petr, Ivan Kanchev, Oldřích Benada, et al.. (2017). KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype. PLoS Genetics. 13(1). e1006566–e1006566. 64 indexed citations
13.
Chalupský, Karel, et al.. (2015). Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase. Antioxidants and Redox Signaling. 23(14). 1076–1091. 72 indexed citations
14.
Brauer, Rena, Jolana Turečková, Ivan Kanchev, et al.. (2015). MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function. Mucosal Immunology. 9(4). 974–985. 22 indexed citations
15.
Chalupský, Karel, Ivan Kanchev, Markéta Jiroušková, et al.. (2013). ADAM10/17-Dependent Release of Soluble c-Met Correlates with Hepatocellular Damage. Folia Biologica. 59(2). 76–86. 28 indexed citations
16.
Gao, Ling, Kin Lung Siu, Karel Chalupský, et al.. (2011). Role of Uncoupled Endothelial Nitric Oxide Synthase in Abdominal Aortic Aneurysm Formation. Hypertension. 59(1). 158–166. 99 indexed citations
17.
18.
Ranaivo, Hantamalala Ralay, Nunzia Carusio, Rosemary Wangensteen, et al.. (2007). Protection Against Endotoxic Shock as a Consequence of Reduced Nitrosative Stress in MLCK210-Null Mice. American Journal Of Pathology. 170(2). 439–446. 36 indexed citations
19.
Oak, Min–Ho, et al.. (2006). Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK.. HAL (Le Centre pour la Communication Scientifique Directe). 4 indexed citations
20.
Lobysheva, Irina, Karel Chalupský, M. Geffard, et al.. (2003). S-Nitrosating Nitric Oxide Donors Induce Long-Lasting Inhibition of Contraction in Isolated Arteries. Journal of Pharmacology and Experimental Therapeutics. 307(1). 152–159. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doina Popov Breakdown of academic impact, for papers by Yasuhiro Irino Breakdown of academic impact, for papers by Akihide Nakao Breakdown of academic impact, for papers by Dongxiao Shen Breakdown of academic impact, for papers by Ken Y. Lin Breakdown of academic impact, for papers by Barbara Coles Breakdown of academic impact, for papers by Wei Cui Breakdown of academic impact, for papers by Kenji Kasuno Breakdown of academic impact, for papers by Alice Habermeier Breakdown of academic impact, for papers by Adrian Manea
Rankless by CCL
2026